Next Article in Journal
Neuropeptide Receptors: Novel Targets for HIV/AIDS Therapeutics
Next Article in Special Issue
A Novel Behavioral Fish Model of Nociception for Testing Analgesics
Previous Article in Journal
Dual-Color Bioluminescence Analysis for Quantitatively Monitoring G-Protein-Coupled Receptor and β-Arrestin Interactions
Previous Article in Special Issue
Opioid Antagonists May Reverse Endogenous Opiate “Dependence” in the Treatment of Self-Injurious Behavior
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2011, 4(3), 470-484;

Myocardial Opioid Receptors in Conditioning and Cytoprotection

Heart Foundation Research Centre, Griffith University, PMB 50 Gold Coast Mail Centre, QLD 9726, Australia
Author to whom correspondence should be addressed.
Received: 25 January 2011 / Revised: 23 February 2011 / Accepted: 28 February 2011 / Published: 4 March 2011
(This article belongs to the Special Issue Opioids)
Full-Text   |   PDF [209 KB, uploaded 4 March 2011]


Opioid compounds and G-protein coupled opioid receptors (ORs) have been studied widely in terms of central nervous system (CNS) actions relating to pain management and drug abuse. Opioids are also linked to induction of mammalian hibernation, a natural state of tolerance involving prolonged and orchestrated shifts in cellular metabolism, growth and stress resistance. It is not surprising then that OR agonism induces acute or delayed cytoprotective states in myocardium, rendering ORs an attractive target for protection of cardiac tissue from the potentially fatal consequences of ischemic heart disease. Cardiac ORs are implicated in triggering/mediating so-called ‘conditioning’ responses, in which powerful cytoprotection arises following transient receptor ligation prior to or immediately following ischemic insult. These responses involve one or more OR sub-types engaging pro-survival kinase cascades to ultimately modulate cell stress and mitochondrial end-effectors. However, important questions remain regarding the role of endogenous opioids, OR signalling, and the transduction and mediation of these protective responses. We briefly review opioid-mediated cardioprotection, focussing on recent developments in signal transduction, the role of receptor ‘cross-talk’, and the effects of sustained OR ligand activation. View Full-Text
Keywords: opioids; preconditioning; postconditioning; cross-talk opioids; preconditioning; postconditioning; cross-talk
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Williams-Pritchard, G.; Headrick, J.P.; Peart, J.N. Myocardial Opioid Receptors in Conditioning and Cytoprotection. Pharmaceuticals 2011, 4, 470-484.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top